| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 900 |
| 1 | METHOTREXATE | 734 |
| 2 | PREDNISONE | 629 |
| 3 | RITUXIMAB | 516 |
| 4 | TOCILIZUMAB | 432 |
| 5 | LEFLUNOMIDE | 422 |
| 6 | BLEOMYCIN SULFATE | 415 |
| 7 | ADALIMUMAB | 412 |
| 8 | AMIODARONE HYDROCHLORIDE | 407 |
| 9 | PEMBROLIZUMAB | 397 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIBACTERIAL HAND WIPES | 106 | 0.3202 |
| 1 | BORIC ACID | 105 | 0.3043 |
| 2 | BENZALKONIUM CHLORIDE 0.13% | 106 | 0.2920 |
| 3 | BENZALKONIUM CHLORIDE | 106 | 0.2442 |
| 4 | GOLD | 220 | 0.0775 |
| 5 | BLEOMYCIN SULFATE | 415 | 0.0404 |
| 6 | VINBLASTINE SULFATE | 78 | 0.0402 |
| 7 | GENTIAN VIOLET | 2 | 0.0385 |
| 8 | AMIODARONE HYDROCHLORIDE | 407 | 0.0365 |
| 9 | DACARBAZINE | 200 | 0.0270 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1077 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 829 |
| 2 | Platinum-based Drug [EPC] | 714 |
| 3 | Alkylating Drug [EPC] | 707 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 668 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 659 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 518 |
| 7 | Microtubule Inhibitor [EPC] | 460 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 433 |
| 9 | Kinase Inhibitor [EPC] | 427 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 11 | 0.0105 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 135 | 0.0067 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 659 | 0.0065 |
| 3 | Nitrofuran Antibacterial [EPC] | 108 | 0.0063 |
| 4 | CD30-directed Immunoconjugate [EPC] | 56 | 0.0055 |
| 5 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 7 | 0.0054 |
| 6 | Lipopeptide Antibacterial [EPC] | 49 | 0.0053 |
| 7 | alpha-1 Adrenergic Agonist [EPC] | 22 | 0.0050 |
| 8 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 29 | 0.0047 |
| 9 | Antirheumatic Agent [EPC] | 422 | 0.0040 |